Features HS OBTAIN
Your app for the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
📚
Learning Tools
Enhance your learning experience with interactive features.
🛡️
Secure & Private
Your data is protected with industry-leading security protocols.
Screenshots
See the HS OBTAIN in Action
Get the App Today
Download on Google Play
Available for Android 8.0 and above